WHO Director-General's keynote speech at the opening night of the World Health Summit – 11 October 2026 - World Health Organization (WHO)
This story deserves to be shared
Send it to someone who'd care, or post it on your networks.
Parliamentary State Secretary Georg Kippels, World Health Summit President Professor Dr Axel Pries, World Health Summit CEO Carsten Schicker, Charité CEO Professor Dr Heyo Kroemer, President of the Robert Koch Institute, Professor Lars Schaade, Excellencies, dear colleagues and friends, Guten Abend! It’s an honour to be here. In our troubled and divided world, it is always a joy to be among friends, and especially friends from the global health family. So I thank Germany and the World Health Summit for bringing our family together. I also thank Germany for its long and strong support for global health and WHO. Nothing symbolizes that support more than the fact that Germany hosts part of WHO right here in Berlin: the WHO Hub for Pandemic and Epidemic Intelligence. The story of the Hub began on 23 October 2020, at the height of the pressures of the COVID-19 pandemic, with an urgent Zoom call with Chancellor Angela Merkel. Our conversation centred on a fundamental truth: viruses move fast, but health data must move even faster. One of the key lessons of the pandemic was the need to strengthen the world’s ability to detect threats faster. The WHO Hub is the answer to that lesson.
This article is an excerpt. To read the full content, visit the original source. World Health Organization (WHO)
Related articles
Patient-centered financial navigation assistance helps reduce financial toxicity among cancer patients - Medical Xpress
Among cancer patients, the high financial cost of cancer care is a prevalent problem. This financial burden is also associated with potentially harmful behavioral strategies that patients might use to cope with costs, such as delaying or forgoing treatment and skipping medications. Collectively, researchers refer to this impact as financial toxicity.
Continuous glucose monitors help type 2 diabetes patients spend 5 more hours a day in healthy blood sugar range - Medical Xpress
Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.
Wearing headphones during surgery may reduce nausea and vomiting afterward - Medical Xpress
Patients who wore noise-canceling headphones during minimally invasive gynecological surgery were significantly less likely to experience postoperative nausea and vomiting (PONV), suggest findings from a randomized clinical trial presented at the Anesthesiology 2026 annual meeting.
Kefah Mokbel: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? - Oncodaily
“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.
0 comments
No comments yet. Be the first to share your thoughts!